| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Of Research &CSO | SVP, Research &CSO
1 company
Gregory Philip D is a SVP Of Research &CSO at SANGAMO THERAPEUTICS, INC. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $20K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2015 | SGMO Sangamo Therapeutics, Inc | SVP Of Research &CSO | Sale+OE | 15,000 | $12.39 | $185,815.50 | -11.4% | |
| May 1, 2015 | SGMO Sangamo Therapeutics, Inc | SVP Of Research &CSO | Sale+OE | 15,000 | $12.62 | $189,370.50 | -11.4% | |
| Apr 1, 2015 | SGMO Sangamo Therapeutics, Inc | SVP Of Research &CSO | Sale+OE | 15,000 | $15.15 | $227,191.50 | -11.4% | |
| Mar 2, 2015 | SGMO Sangamo Therapeutics, Inc | SVP Of Research &CSO | Sale+OE | 15,000 | $17.26 | $258,937.50 | -11.4% | |
| Feb 2, 2015 | SGMO Sangamo Therapeutics, Inc | SVP Of Research &CSO | Sale+OE | 15,000 | $12.86 | $192,829.50 | -11.4% | |
| Jan 2, 2015 | SGMO Sangamo Therapeutics, Inc | SVP, Research &CSO | Sale+OE | 15,000 | $15.78 | $236,664.00 | -11.4% |